Results 201 to 210 of about 84,688 (355)

Does Guideline-Directed Medical Therapy Reduce the Incidence of Ventricular Arrhythmias in Patients With HFrEF? [PDF]

J Arrhythm
Nomoto Y, Kataoka N, Imamura T.
europepmc   +1 more source

Telmisartan (micardis) - an antagonist of angiotensin II receptors of type 1: one more antihypertensivedrug or something greater?

, 2003
I E Chazora
openalex   +1 more source

EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN TREATMENT OF EXPERIMENTAL BULLOUS PULMONARY EMPHYSEMA [PDF]

, 2019
Artem Mikheev, Sergey Trushin
openalex   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Association Between Pre-hospital Medication Use and Outcomes in Patients Hospitalized for COVID-19 Pneumonia: A Multicenter Observational Study in the Netherlands. [PDF]

Cureus
Li L, Goris-de Geus J, de Leeuw I, Kanits F, Zegers J, van Zadelhoff A, Buenen N, Rettig TCD, Hoir MPL, Duijzer G, Geleijnse JM, Endeman H.   +11 more
europepmc   +1 more source

Angiotensin II Receptor Antagonist [PDF]

, 2020
openaire   +1 more source

Angiotensin receptor-neprilysin inhibitors improve the outcome of lung cancer patients with hypertension undergoing immune checkpoint inhibitors treatment. [PDF]

BMC Cardiovasc Disord
Shang C, Wang H, Chen J, Cao S, Sun Y, Sheng Z, Chu T, Zhao L.   +7 more
europepmc   +1 more source

Synthesis and Angiotensin II Receptor Antagonist Activity of C-Linked Pyrazole Derivatives.

, 1994
Eric Nicolaï, G. CURE, J. GOYARD, Max Kirchner, Jean‐Marie Teulon, A. VERSIGNY, Michèle Cazes, Angéla Virone-Oddos, F. Caussade, Alix Cloarec   +9 more
openalex   +2 more sources

Health Benefits of Polysaccharides in Red Algae: A Comprehensive Review

Food Frontiers, EarlyView.
Graphical abstract showing the health benefits of red algal polysaccharides. ABSTRACT Humans have long consumed red algae (especially by the Asian community), and their polysaccharide extracts (carrageenan, agar) are extensively used in the food industry as gel thickeners.
Sammueal Jun Kai Ong, Matthew Myint, Sean Chia, Chee Fan Tan, Yi Fan Hong, Meiyappan Lakshmanan, Ying Swan Ho, Thomas T. Wheeler, Xuezhi Bi, Ian Walsh, Kuin Tian Pang   +10 more
wiley   +1 more source

Combination therapy with mineralocorticoid receptor antagonists and SGLT2 inhibitors versus SGLT2 inhibitor monotherapy in chronic kidney disease: an updated meta-analysis of randomized controlled trials. [PDF]

BMC Nephrol
Muhammad Daniyal S, Ajaz H, Riaz M, Murad Khatoon N, Aftab Z, Tauqir Gondal H, Gul I, Sarwar M, Batool F, Fahim SL, Noor A, Khalid A, Ashraf DA, Jabarkhil R.   +13 more
europepmc   +1 more source